The single most underinvested step in international pharmaceutical market expansion is partner qualification. Companies allocate months and significant budget to regulatory strategy development, commercial projections, and market analysis, then select a distributor, co-development partner, or licensing counterparty through a network introduction and a favorable first meeting.